Paediatric Type1 Diabetes Management and Mothers' Emotional Intelligence Interactions

Jolanta Žilinskienė1, Linas Šumskas2, Dalia Antinienė1

  • 1Department of Health Psychology, Faculty of Public Health, Lithuanian University of Health Sciences, A. Mickevičiaus Street 9, LT-44307 Kaunas, Lithuania.

Insights

Mothers with higher emotional intelligence (EI) demonstrate better management of their children's type I diabetes (T1DM). Specifically, understanding and regulating emotions positively impacts children's glycaemic control.

Area of Science:

  • Pediatric Endocrinology
  • Psychology
  • Health Psychology

Background:

  • Parental emotional well-being significantly influences child health.
  • Emotional intelligence (EI) in caregivers is a potential factor in managing chronic childhood conditions.
  • Type I diabetes (T1DM) in children requires consistent and effective disease management.

Purpose of the Study:

  • To investigate the association between maternal emotional intelligence (EI) and the management of pediatric type I diabetes (T1DM).
  • To determine if maternal EI predicts glycaemic control in children with T1DM.
  • To explore specific EI components related to T1DM disease management.

Main Methods:

  • Survey of 134 mothers of children (aged 6-12 years) with T1DM.
  • Assessment of maternal emotional intelligence using EI scales.
  • Measurement of paediatric T1DM management via HbA1c levels.
  • Logistic regression analysis to assess EI-T1DM management associations.

Main Results:

  • Maternal EI scales and subscales showed significant associations with glycaemic management indices (HbA1c).
  • Specific EI components, including understanding/controlling own emotions and transforming negative emotions, were statistically significant predictors.
  • Mothers' ability to manage their own emotions correlated with better T1DM management in their children.

Conclusions:

  • Maternal emotional intelligence is a reliable predictor of glycaemic control in children with T1DM.
  • Targeting maternal EI may offer a novel approach to improving pediatric T1DM management.
  • The emotional regulation capacities of mothers are crucial for effective diabetes care in children.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
682
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
378
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K